Clinical Trial Update: Onabotulinumtoxin A Versus Kenalog for Chronic Pelvic Pain [NA]

View source ↗

Summary

A completed clinical trial comparing onabotulinumtoxin A to Kenalog for chronic pelvic pain; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pelvic Pain

Drugs mentioned

• Kenalog (triamcinolone acetonide)
• Onabotulinumtoxin A (botulinum toxin type A)

Snippet

Sponsor: Jamie Bartley, DO | Conditions: Pelvic Pain | NA | Status: COMPLETED | Results posted: 2019-02-06